SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer

BMC Cancer

Volumn 11, Issue , 2011, Pages

  Neumann, Jens ^a   Bahr, Fiorina ^a   Horst, David ^a,b   Kriegl, Lydia ^a   Engel, Jutta ^a   Luque, Raquel M ^c   Gerhard, Markus ^c   Kirchner, Thomas ^a   Jung, Andreas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

catenin; Colon cancer; Metastasis; Sox2

Indexed keywords

BETA CATENIN; CYTOPLASM PROTEIN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUMOR PROTEIN;

AGED; ARTICLE; CANCER GRADING; CASE CONTROL STUDY; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR VOLUME; ADENOCARCINOMA; COLON TUMOR; METABOLISM; METASTASIS; MIDDLE AGED;

ADENOCARCINOMA; AGED; BETA CATENIN; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; SOXB1 TRANSCRIPTION FACTORS;

EID: 83355172205     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-11-518     Document Type: Article

References (40)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60(5):277-300. 10.3322/caac.20073, 20610543.
2. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007, 50(1):113-130. 10.1111/j.1365-2559.2006.02549.x, 17204026.
3. Kim JC, Cho YK, Roh SA, Yu CS, Gong G, Jang SJ, Kim SY, Kim YS. Individual tumorigenesis pathways of sporadic colorectal adenocarcinomas are associated with the biological behavior of tumors. Cancer Sci 2008, 99(7):1348-1354. 10.1111/j.1349-7006.2008.00819.x, 18422752.
4. Ogino S, Goel A. Molecular classification and correlates in colorectal cancer. J Mol Diagn 2008, 10(1):13-27. 10.2353/jmoldx.2008.070082, 2175539, 18165277.
5. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127(3):469-480. 10.1016/j.cell.2006.10.018, 17081971.
6. Jung A, Brabletz T, Kirchner T. The migrating cancer stem cells model--a conceptual explanation of malignant tumour progression. Ernst Schering Found Symp Proc 2006, (5):109-24.
7. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L, Jass JR. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Histopathology 2007, 50(4):453-464. 10.1111/j.1365-2559.2007.02620.x, 17448021.
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674. 10.1016/j.cell.2011.02.013, 21376230.
9. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat Rev Cancer 2005, 5(9):744-749. 10.1038/nrc1694, 16148886.
10. Hiendlmeyer E, Regus S, Wassermann S, Hlubek F, Haynl A, Dimmler A, Koch C, Knoll C, van Beest M, Reuning U, et al. Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res 2004, 64(4):1209-1214. 10.1158/0008-5472.CAN-3627-2, 14973118.
11. Beiter K, Hiendlmeyer E, Brabletz T, Hlubek F, Haynl A, Knoll C, Kirchner T, Jung A. Beta-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 2005, 24(55):8200-8204.
12. Wassermann S, Scheel SK, Hiendlmeyer E, Palmqvist R, Horst D, Hlubek F, Haynl A, Kriegl L, Reu S, Merkel S, et al. p16INK4a is a beta-catenin target gene and indicates low survival in human colorectal tumors. Gastroenterology 2009, 136(1):196-205 e192. 10.1053/j.gastro.2008.09.019, 18951899.
13. Wong SC, Lo ES, Chan AK, Lee KC, Hsiao WL. Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong. Mol Pathol 2003, 56(6):347-352. 10.1136/mp.56.6.347, 1187354, 14645698.
14. Wong SC, Lo ES, Lee KC, Chan JK, Hsiao WL. Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer. Clin Cancer Res 2004, 10(4):1401-1408. 10.1158/1078-0432.CCR-0157-03, 14977843.
15. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40(5):499-507. 10.1038/ng.127, 2912221, 18443585.
16. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol 2008, 26(1):101-106. 10.1038/nbt1374, 18059259.
17. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872. 10.1016/j.cell.2007.11.019, 18035408.
18. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676. 10.1016/j.cell.2006.07.024, 16904174.
19. Ong CW, Kim LG, Kong HH, Low LY, Iacopetta B, Soong R, Salto-Tellez M. CD133 expression predicts for non-response to chemotherapy in colorectal cancer. Mod Pathol 2010, 23(3):450-457. 10.1038/modpathol.2009.181, 20081809.
20. Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol 2009, 16(12):3488-3498. 10.1245/s10434-009-0617-z, 19657699.
21. Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn 2010, 239(1):56-68.
22. Jaenisch R. Stem cells, pluripotency and nuclear reprogramming. J Thromb Haemost 2009, 7(Suppl 1):21-23.
23. Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 2006, 9(3):156-166. 10.1007/s10120-006-0375-6, 16952033.
24. Park ET, Gum JR, Kakar S, Kwon SW, Deng G, Kim YS. Aberrant expression of SOX2 upregulates MUC5AC gastric foveolar mucin in mucinous cancers of the colorectum and related lesions. Int J Cancer 2008, 122(6):1253-1260.
25. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol 2003, 16(4):376-388. 10.1097/01.MP.0000062859.46942.93, 12692203.
26. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005, 23(33):8512-8519. 10.1200/JCO.2005.04.0063, 16260687.
27. Van den Eynde M, Hendlisz A. Treatment of colorectal liver metastases: a review. Rev Recent Clin Trials 2009, 4(1):56-62. 10.2174/157488709787047558, 19149763.
28. Wong DJ, Liu H, Ridky TW, Cassarino D, Segal E, Chang HY. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell 2008, 2(4):333-344. 10.1016/j.stem.2008.02.009, 2628721, 18397753.
29. Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010, 12(5):468-476. 10.1038/ncb2048, 20418870.
30. Pang R, Law WL, Chu AC, Poon JT, Lam CS, Chow AK, Ng L, Cheung LW, Lan XR, Lan HY, et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010, 6(6):603-615. 10.1016/j.stem.2010.04.001, 20569697.
31. Horst D, Kriegl L, Engel J, Jung A, Kirchner T. CD133 and nuclear beta-catenin: the marker combination to detect high risk cases of low stage colorectal cancer. Eur J Cancer 2009, 45(11):2034-2040. 10.1016/j.ejca.2009.04.004, 19403300.
32. Horst D, Kriegl L, Engel J, Kirchner T, Jung A. CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer 2008, 99(8):1285-1289. 10.1038/sj.bjc.6604664, 2570510, 18781171.
33. Horst D, Scheel SK, Liebmann S, Neumann J, Maatz S, Kirchner T, Jung A. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. J Pathol 2009, 219(4):427-34. 10.1002/path.2597, 19621338.
34. Mansukhani A, Ambrosetti D, Holmes G, Cornivelli L, Basilico C. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 2005, 168(7):1065-1076. 10.1083/jcb.200409182, 2171836, 15781477.
35. Chen Y, Shi L, Zhang L, Li R, Liang J, Yu W, Sun L, Yang X, Wang Y, Zhang Y, et al. The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 2008, 283(26):17969-17978. 10.1074/jbc.M802917200, 18456656.
36. Van Raay TJ, Moore KB, Iordanova I, Steele M, Jamrich M, Harris WA, Vetter ML. Frizzled 5 signaling governs the neural potential of progenitors in the developing Xenopus retina. Neuron 2005, 46(1):23-36. 10.1016/j.neuron.2005.02.023, 15820691.
37. Fang X, Yu W, Li L, Shao J, Zhao N, Chen Q, Ye Z, Lin SC, Zheng S, Lin B. ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. OMICS 2010, 14(4):369-384. 10.1089/omi.2010.0053, 20726797.
38. Sinner D, Kordich JJ, Spence JR, Opoka R, Rankin S, Lin SC, Jonatan D, Zorn AM, Wells JM. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol Cell Biol 2007, 27(22):7802-7815. 10.1128/MCB.02179-06, 2169141, 17875931.
39. Topol L, Chen W, Song H, Day TF, Yang Y. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem 2009, 284(5):3323-3333. 2631972, 19047045.
40. Guo L, Zhong D, Lau S, Liu X, Dong XY, Sun X, Yang VW, Vertino PM, Moreno CS, Varma V, et al. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 2008, 6(9):1421-1430. 10.1158/1541-7786.MCR-07-2175, 2652859, 18819930.